Suppr超能文献

氨肽酶抑制剂对肿瘤细胞侵袭和基质降解的抑制作用。

Inhibition of tumor cell invasion and matrix degradation by aminopeptidase inhibitors.

作者信息

Fujii H, Nakajima M, Aoyagi T, Tsuruo T

机构信息

Institute of Molecular and Cellular Biosciences, University of Tokyo, Japan.

出版信息

Biol Pharm Bull. 1996 Jan;19(1):6-10. doi: 10.1248/bpb.19.6.

Abstract

We investigated the effects of several types of aminopeptidase inhibitors on tumor cell-associated aminopeptidase activity and invasion. The aminopeptidase expressed by the human metastatic HT1080 fibrosarcoma cells was effectively suppressed by actinonin A, bestatin, leuhistin and matlystatin A, which are capable of inhibiting the purified aminopeptidase N, but not by arphamenine B specific for aminopeptidase B. The aminopeptidase N inhibitors inhibited HT1080 cells from degrading the subendothelial matrix and from invading into Matrigel in parallel with their aminopeptidase inhibitory activities. Matlystatin A, with multiple inhibitory activity against both aminopeptidase N and matrix metalloproteinases (MMP), was the most effective inhibitor of invasion. However, leuhistin and bestatin, without MMP inhibitory activity, also exhibited significant inhibition of invasion. The results suggest that aminopeptidase N plays a crucial role in the degradation and invasion of extracellular matrices by fibrosarcoma cells and that aminopeptidase inhibitors may be useful for preventing the spread of malignant tumors.

摘要

我们研究了几种类型的氨肽酶抑制剂对肿瘤细胞相关氨肽酶活性及侵袭的影响。人转移性HT1080纤维肉瘤细胞表达的氨肽酶可被Actinonin A、抑氨肽酶素、亮抑蛋白酶肽和马立司他A有效抑制,这些抑制剂能够抑制纯化的氨肽酶N,但对氨肽酶B特异的阿弗他明B则无抑制作用。氨肽酶N抑制剂抑制HT1080细胞降解内皮下基质及侵袭基质胶的能力与其氨肽酶抑制活性呈平行关系。对氨肽酶N和基质金属蛋白酶(MMP)均具有多重抑制活性的马立司他A是最有效的侵袭抑制剂。然而,不具有MMP抑制活性的亮抑蛋白酶肽和抑氨肽酶素也表现出显著的侵袭抑制作用。结果表明,氨肽酶N在纤维肉瘤细胞对细胞外基质的降解及侵袭过程中起关键作用,且氨肽酶抑制剂可能对预防恶性肿瘤的扩散有用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验